• Privacy Policy
  • Terms and Conditions
  • Contact
Saturday, May 24, 2025
Pharma Info Nepal
No Result
View All Result
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Study Materials

Pregnancy Categories Medicine

Pregnancy Categories Medicine

Nabin Bista by Nabin Bista
June 2, 2021
in Study Materials
0
Pregnancy Categories Medicine
1.2k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Pregnancy Categories Medicine

Some women need to take medicines during pregnancy for health problems like diabetes, depression, morning sickness or seizures. Always talk with your doctor, nurse, or pharmacist before taking any medicines, vitamins or herbs. Don’t stop taking your prescription medicines unless your healthcare provider says that it is OK.

Pregnancy can be an exciting time. However, this time can also make you feel uneasy if you are not sure how your medicines will affect your baby. Not all medicines are safe to take when you are pregnant. Even headache or pain medicine may not be safe during certain times in your pregnancy.

Always talk to your doctor, nurse, or pharmacist before you take any medicines, herbs, or vitamins. Don’t stop taking your medicines until your healthcare provider says that it is OK.

FDA Pregnancy Risk Categories.

In 1979, the FDA established five letter risk categories – A, B, C, D or X – to indicate the potential of a drug to cause birth defects if used during pregnancy. The categories were determined by assessing the reliability of documentation and the risk to benefit ratio. These categories did not take into account any risks from pharmaceutical agents or their metabolites in breast milk. In the drug product label, this information was found in the section “Use in Specific Populations”.

The former pregnancy categories, which still may be found in some package inserts, were as follows:

Category A

Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

Example drugs or substances: levothyroxine, folic acid, liothyronine,Thiamine, Pyridoxine, Docusate, Senna, Bisacodyl, Dextromethorphan, Doxylamine, Isoniazid

Category B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk

Antibiotics
Penicillin V, Penicillin G Benzathine, Amoxicillin, Amoxicillin/Clavulanate, Oxacillin, Ampicillin, Ampicillin/Sulbactam, Ticarcillin/Clavulanate, Dicloxacillin, Cloxacillin, Nafcillin, Ceftriaxone, Cephalexin, Cefazolin, Cefepime, Cefuroxime, Ceftaroline fosamil, Cefdinir, Cefadroxil, Cefpodoxime, Cefprozil, Ceftolozane/tazobactam, Cefditoren Clindamycin, Azithromycin, Erythromycin, Fidaxomicin, Spiramycin Metronidazole Daptomycin, Nitrofurantoin, Fosfomycin Aztreonam, Meropenem, Ertapenem, Doripenem Mupirocin Quinupristin/dalfopristin

Other Antimicrobials
Acyclovir, Famciclovir, Valacyclovir, Amphotericin B, Clotrimazole (topical, vulvovaginal), Terbinafine, Mefloquine Permethrin, Emtricitabine/tenofovir (Truvada), Nitazoxanide, Praziquantel, Raxibacumab

Antiemetics and other GI medications
Metoclopramide, Ondansetron, Dimenhydrinate, Famotidine, Lansoprazole, Pantoprazole, Lactulose, Psyllium, Loperamide, Dicyclomine, Ursodiol, Sucralfate
Analgesics and other Drugs
Acetaminophen, Ketamine, Meperidine, Cyclobenzaprine, Indomethacin, Meclizine, Clozapine, Benztropine, Buspirone, Methylphenidate

Cardiovascular Medications
Hydrochlorothiazide, Fenoldopam, Torsemide, Ethacrynic acid, Amiloride, Epoprostenol (prostacyclin), Sildenafil, Dobutamine, Sotalol

Antiplatelet and Anticoagulants
Clopidogrel, Prasugrel, Eptifibatide, Ticlopidine, Tirofiban, Apixaban, Argatroban, Bivalirudin, Fondaparinux, Enoxaparin, Antidotes, EDTA, Levocarnitine, Cyproheptadine, Idarucizumab, N-acetylcysteine

Miscellaneous
Ipratropium, Budesonide, Ranitidine, Cimetidine, Metformin, Oxybutynin, Tamsulosin, Phenazopyridine, Bromocriptine, Glycopyrrolate, Montelukast, Desmopressin, Glucagon, Prilocaine, Propofol, Sodium polystyrene sulfonate, Sulfasalazine

Category C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

Example drugs: gabapentin, amlodipine, trazodone

Category D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

Example drugs:

Antimicrobials
Gentamicin, Neomycin, Amikacin, Streptomycin, Kanamycin, Trimethoprim-sulfamethoxazole, Doxycycline, Minocycline, Tetracycline, Tigecycline, Fluconazole, Voriconazole, Primaquine, Hydroxychloroquine

AEDs and other neuro/psych medicines 
Phenytoin, Fosphenytoin, Carbamazepine, Midazolam, Alprazolam, Clonazepam, Diazepam, Phenobarbital, Magnesium sulfate (despite being drug-of-choice for eclampsia), Lithium, Topiramate, Pentobarbital,

Cardiovascular
Amiodarone, Atenolol, Lisinopril, Captopril, Enalapril, Benazepril, Losartan, Valsartan, Aspirin (3rd trimester), Edoxaban, Warfarin

Miscellaneous

Cortisone, Flunisolide, Mycophenolate mofetil, Penicillamine, Methimazole, Propylthiouracil, Potassium iodide, Hydroxyurea, Zoledronate, Bismuth subsalicylate (3rd trimester only), Cyclophosphamide, Ibuprofen (3rd trimester only, otherwise category C), Meloxicam (if >30wks, otherwise category C), Tamoxifen

Category X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits. Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

Example drugs: Atorvastatin, Simvastatin, Methotrexate, Finasteride, Valproate, Ribavirin, Triazolam, Bosentan, Aliskiren, Levonorgestrel, Ulipristal, Griseofulvin, Methylene blue, Oxytocin, Riociguat, Isotretinoin

 



  • Principles of Drug Action
  • Adverse Drug Reaction (ADR)
  • Don’t Use Some Drugs with Grapefruit


Follow us on Facebook : Pharma Info Nepal 

Tags: Medicine InformationStudy Materials
Previous Post

Pharmacology Facts Every Pharmacist Should Know

Next Post

Pharmacy Service Criteria as Per Health Institution Operation Standard 2077

Nabin Bista

Nabin Bista

Hello, Thank You for visiting my blog I am Nabin Bista, Dedicated and self motivated young Registered Pharmacist from Nepal. Blogging is my passion. I did my B Pharmacy from Institute of Medicine - IOM, Currently working as Hospital Pharmacist at Patan Academy of Health Sciences (PAHS). If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

Related Posts

Pharmaceutical Calculations MCQs – 30 Questions with Answers
B Pharmacy

Pharmaceutical Calculations MCQs – 30 Questions with Answers

May 22, 2025
Understanding the Relationship Between BCS Classification and IVIVC
Pharmacy Notes

Understanding the Relationship Between BCS Classification and IVIVC: A Key to Smarter Drug Development

May 16, 2025
Medicines in the National Health Policy
Loksewa

Provisions Related to Medicines in the National Health Policy | Loksewa Frequently Asked Question

April 16, 2025
Understanding Types of Insulin: 30/70, 50/50, Lispro, Aspart, Regular & Glargine
Pharmacy Notes

Understanding Types of Insulin: 30/70, 50/50, Lispro, Aspart, Regular & Glargine

April 13, 2025
Line Clearance in Pharmaceutical Industry : Why it matters?
Pharmacy Notes

Line Clearance in Pharmaceutical Industry : Why it matters?

April 6, 2025
Foracort vs. Seroflo: Understanding Their Uses and Differences
Pharmacy Notes

Foracort vs. Seroflo: Understanding Their Uses and Differences

April 5, 2025
Load More
Next Post
Pharmacy Service Criteria as Per Health Institution Operation Standard 2077

Pharmacy Service Criteria as Per Health Institution Operation Standard 2077

Discussion about this post

Recommended

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

May 24, 2025
Pharmaceutical Calculations MCQs – 30 Questions with Answers

Pharmaceutical Calculations MCQs – 30 Questions with Answers

May 22, 2025
Vacancy Announcement at Simca Laboratories Pvt. Ltd

Vacancy Announcement at Simca Laboratories Pvt. Ltd

May 22, 2025
Best NPC License Preparation Classes in Nepal for Pharmacy Students

Best NPC License Preparation Classes in Nepal for Pharmacy Students

May 22, 2025
WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

May 21, 2025
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

Important Information

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

Categories

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy

DOWNLOADS

Pharmacy Book 

Pharmacy Act and Guidelines

About Pharma Info Nepal

About Admin

  • About Pharma Info Nepal 
  • Contact
  • Courses
  • Home
  • Instructors
  • Nabin Bista
  • Pharmacy Act and Guidelines
  • Pharmacy Books
  • Privacy Policy
  • Profile
  • Terms and Conditions
  • Terms Of Use

© 2025 Pharma Info Nepal | All Rights Reserved

error:
No Result
View All Result
  • Courses
  • Questions
  • Downloads
  • About Pharma Info Nepal 

© 2025 Pharma Info Nepal | All Rights Reserved